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Abstract High affinity IgE receptors (a~/2) mediate the acti- 
vation of the non-receptor tyrosine kinases Lyn and Syk. Here 
we show that the antioxidant drug N-acetyl-L-cysteine (NAC) 
inhibits antigen-mediated Syk activation whereas Lyn activation 
and phosphorylation of I~ and -/ is maintained. Furthermore, 
NAC inhibits antigen-mediated calcium mobilization and exocy- 
tosis in a dose-dependent manner, but does not inhibit ionomycin- 
induced exocytosis. These data support a model in which the 
activation of Lyn is responsible for receptor phosphorylation and 
precedes the activation of Syk. The inhibition of Syk activation 
by NAC may be relevant o B and T cell antigen receptors, which 
are also linked to Syk/ZAP'/0 tyrusine kinases. 
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also suggested that FceRI 7/associates with Syk and are consis- 
tent with our model [5, 6] 
Oxidants and antioxidants are being increasingly used in 
studies of cell function. These include studies on growth regula- 
tion [20], apoptosis [21] and HIV-replication [22]. It is now well 
established that oxidizing conditions induce tyrosine kinase 
activation and protein phosphorylation [23 26]. However, the 
effect of antioxidants on tyrosine kinases has not been studied. 
In this report, we have investigated whether N-acetyl-L-cysteine 
(NAC), an antioxidant drug which can enter cells readily, could 
modulate cellular activation. We analyzed the effects of NAC 
on antigen-mediated protein phosphorylations, tyrosine kinase 
activation, calcium mobilization and exocytosis. 
2. Materials and methods 
I. Introduction 
Antigen/IgE complexes induce exocytosis in mast cells by 
clustering high affinity IgE receptors (FceRI). Engagement of 
the tetrameric (~fl~'2) FceRI receptors mediates the activation 
of the non-receptor tyrosine kinases Lyn and Syk [1-6]. The 
activation of these kinases leads to the phosphorylation of 
various substrates including the fl and ?' receptor subunits 
[7 10], the phospholipase C-y [10-12], and the GTP/GDP ex- 
change factor vav [13]. These phosphorylation events are fol- 
lowed by the hydrolysis of phosphoinositides and the genera- 
tion of inositol 1,4,5 triphosphate (IP3) , the later responsible for 
the release of calcium from the endoplasmic reticulum [14-18]. 
A functional rote for Syk in cell surface signaling was initially 
recognized by the observation that a chimeric protein contain- 
ing Syk induces protein phosphorylation of several substrates 
including PLC-yl ,  and is sufficient for the generation of a Ca 2+ 
signal [19]. We have recently proposed a model of FceRI acti- 
vation in which Lyn is responsible for the phosphorylation of
the fl and y receptor subunits [4]. These phosphorylation events 
are followed by an association of Syk with phosphorylated 7/ 
thereby promoting the activation of Syk [4]. Other studies have 
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2.1. Reagents" and antibodies 
Media and sera were purchased from Biofluids, Rockville, MD. 
Dinitrophenyl[30]human serum albumin (DNP-HSA, 30 molecules of 
DNP per molecule of HSA) was from Sigma (St. Louis, MO). N-acetyl- 
L-cysteine was obtained from Aldrich (Milwaukee, WI). Fura-2 was 
from Molecular Probes Inc, (Eugene, OR). Radiochemicals were pur- 
chased either from Amersham ([32p]orthophosphate, Cat. No. 
PBS.13A) or DuPont-NEN ([3H]serotonin, Cat. No. NEC-225 and 
[),-32p]ATE Cat. No. NEG 002H). The anti-phosphotyrosine (4GI0) 
and anti-PLC-yl antibodies were from Upstate Biotechnology, Inc. 
(Lake Placid, NY), the anti-Lyn antibody was from Santa Cruz Bio- 
technology, Inc. (Santa Cruz, CA). The rabbit anti-Syk antibody (996), 
the anti-FceRI fl subunit antibody (JRK), and the DNP-specific mon- 
oclonal mouse IgE (Hi-DNP e 26.82) were described previously 
[4,27,28]. 
2.2. Cell culture and serotonin release experiments' 
The RBL-2H3 cell line culture and serotonin release assays were 
performed as described previously [12]. The assay buffer contained: 
25 mM Na~PIPES, pH 7.1, 100 mM NaC1, 5 mM KC1, 0.4 mM MgC1, 
1 mM CaCI2, 5 mM D-glucose, and 0.1% BSA. 
2.3. Calcium flux measurements" 
RBL-2H3 cells were loaded at 5 × 106 cells/ml for 45 min at 37°C with 
the acetoxymethyl ester of fura-2 (2/~M). The buffer was identical to 
the one used for serotonin release xcept for the addition of 2.5 mM 
probenecid. Cells were analyzed in a cuvette on a Deltascan 4000 
spectrofluorimeter (Photon Technology International Inc., South 
Brunswick, NJ) with excitation set at 340 nm and 380 nm and emission 
at 500 nm. Calcium concentrations were calculated using the published 
value of 2.24 x 10 -7 for the Kd of fura-2 at 37°C [29]. 
2.4. Phosphorylation on intact cells, immunoprecipitation and 
immunoblotting 
In vivo phosphorylations and immunoprecipitations were performed 
as previously described [4,31]. The lysis buffer (pH 8.0) contained 200 
mM boric acid, 150 mM NaCl, 0.5 or 1% Triton X-100, 1% BSA, 
phosphatase inhibitors (1 mM sodium orthovanadate, 5 mM sodium 
fluoride, 5 mM sodium pyrophosphate, and 5 mM EDTA), and the 
following protease inhibitors: 10 ¢tg/ml aprotinin, 4/zg/ml eupeptin, 
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10 #g/ml pepstatin, 1 #M phenylmethylsulfony fluoride (PMSF). Im- 
munoblots were performed as previously reported [4,12]. 
2.5. In vitro kinase assay 
RBL-2H3 cells (5 x l0  7 cells per sample) were lysed in the buffer 
described above. The kinase reaction was performed as described [30]. 
The kinase buffer contained: 30 mM HEPES, 5 mM MgC12, 5 mM 
MnC12, 1 #M ATP, 12.5,uCi of D,-32P]ATR and 100,uM sodium ortho- 
vanadate. The immunoprecipitates w re separated by SDS-PAGE and 
the gel analyzed by autoradiography. Radioactivity in the region of the 
gel corresponding tothe kinases were quantitated using a radioanalytic 
imaging system (AMBIS Systems, San Diego, CA). The proteins were 
then transfered to Immobilon filters and assessed by specific anti-Syk 
or anti-Lyn immunoblots. Amount of precipitated kinases was quanti- 
tated with a computing densitometer (Molecular Dynamics System, 
Sunnyvale, CA). The activity of the kinase was estimated before and 
after cell activation by normalizing the kinase activity for the amount 
of precipitated kinase, and the ratio triggered/non triggered of kinase 
activity was determined. 
3. Results 
3.1. Inhibition of antigen-mediated protein phosphorylation by 
NAC in RBL-2H3 cells 
We first tested the effect of NAC on the viability of RBL-2H3 
cells under our experimental conditions. During an incubation 
time of 30 min, NAC (10 mM) did not affect cell viability as 
assessed by trypan blue exclusion (data not shown). We then 
analyzed the effect of NAC on the phosphorylation of sub- 
strates induced by antigen. RBL-2H3 cells were saturated with 
anti-DNP IgE, labeled in vivo with [32p]phosphoric a id and 
incubated or not with NAC (10 mM) for 2 min. Cells were then 
stimulated (or not) with the multivalent antigen DNP-HSA 
(100 ng/ml, 1 min). After cell lysis, the phosphorylated proteins 
were immunoprecipitated with anti-phosphotyrosine antibod- 
ies (anti-PY), separated by SDS-PAGE and autoradiographed 
(Fig. 1, panel a). The proteins from the same gel were then 
transferred to Immobilon filters and analyzed on anti-FceRI fl 
or anti-Syk immunoblots (Fig. 1, panel b). 
As already reported [8 13], FceRI crosslinking by antigen 
induced phosphorylation f various substrates (Fig. la, lanes 
1-2). Specific immunoblots (Fig. lb) revealed that the 32 kDa 
and the 72 kDa molecules were, respectively, the FceRI'8 chain 
and the tyrosine kinase Syk. Similarly, the 10 kDa molecule was 
identified as the FceRI y chain (data not shown). Note that the 
,8 chain appears as a doublet on the immunoblot as reported 
previously [7,9], while only the top band corresponds to 
phosphorylated '8. 
In NAC treated cells, the antigen-mediated phosphorylation 
of several substrates, including the 72 kDa molecule, was abol- 
ished whereas the phosphorylation f other substrates includ- 
ing the 10 kDa, 32 kDa, and 180 kDa molecules was maintained 
(Fig. la, lanes 34).  Immunoblots (Fig. lb) revealed that FceRI 
'8 chain (the doublet around 32 kDa), and FceRI ), chain (data 
not shown) but not Syk kinase (the 72 kDa molecule) are 
among the remaining phosphorylated substrates following re- 
ceptor clustering in NAC treated cells. Phosphorylation of a 
non identified 180 kDa molecule was also unaffected by NAC. 
Thus NAC inhibits antigen-mediated Syk phosphorylation, but 
not '8 and ), phosphorylation. 
3.2. Effect of NA C on antigen-mediated tyrosine kinase 
activation in RBL-2H3 cells 
We then determined by in vitro kinase assays whether the 
a 
i 
NAC ( I0  rnM) 
I - -  
DNP-HSA 
Mr200 -
97.4 - 
69 -  
46-  
30-  
b 
Fig. 1. 
21.5 - 
14.3 - 
anti-PY 
I 
- + 
] i I 
+ + 
~--Syk 
Fc~RI  13 cha in  
FceRI  Y cha in  
Blot with: 
I 
69-  ~ ]~ant i -Syk  
30-  ]~ant i -Fc~RI  13 chain 
Effect of NAC on antigen-induced protein tyrosine 
phosphorylations. RBL-2H3 cells (5 x 10 7 cells per sample), were satu- 
rated with anti-DNP IgE and in vivo labelled with [32p]phosphoric acid 
at 37°C as described in section 2. Cells were incubated (or not) with 10 
mM of NAC (for 2 min) and triggered (or not) with antigen (DNP- 
HSA, 100 ng/ml) for 1 min in the continuous presence of NAC. After 
lysis of the cells, proteins were immunoprecipitated, as indicated, and 
separated on 13 % SDS-PAGE under educing conditions. (a) Autoradi- 
ograph of proteins immunoprecipitated with anti-phosphotyrosine 
(anti-PY) antibodies. (b) The same immunoprecipitates were analyzed 
by immunoblotting with either anti-FceRI fl chain or anti-Syk antibod- 
ies, as indicated. 
tyrosine kinases Lyn and Syk, i.e. two kinases known to interact 
with FcERI [4-6], were affected by treatment of intact cells with 
NAC. RBL-2H3 cells were saturated with anti-DNP IgE, 
treated (or not) with 10 mM NAC for 2 min and then stimu- 
lated (or not) with 1 #g/ml DNP-HSA for 30 s. The cells were 
lysed and Syk or Lyn kinases were immunoprecipitated with 
specific antibodies. The immunoprecipitates were subjected to 
in vitro kinase reactions with [y-32p]ATP and analyzed by SDS- 
PAGE and autoradiography. The amount of precipitated ki- 
nases in each condition was assessed by specific anti-Syk or 
anti-Lyn immunoblots. As already reported [1-6], FceRI 
crosslinking by antigen induces Syk (Fig. 2a, lanes 1-2) and Lyn 
activation (Fig. 2b, lanes 1-2). NAC inhibited antigen-mediated 
Syk activation (Fig. 2a, lanes 34)  whereas Lyn activation is 
maintained (Fig. 2b, lanes 34).  Quantitative analysis per- 
formed by using a radioanalytic imaging system and a comput- 
ing densitometer revealed that the triggered/non triggered ra- 
tio of Lyn activity (see section 2) was equivalent in non treated 
cells and in NAC treated cells. By contrast, the triggered/non 
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Fig. 2. In vitro kinase assays: effect of NAC on antigen-induced Lyn, 
and Syk activation. RBL-2H3 cells saturated with anti-DNP IgE were 
incubated (or not) with NAC (10 mM) and triggered (or not) with 
DNP-HSA (1 #g/ml for 30 s). Immunoprecipitates w re subjected toin 
vitro kinase assays as described inMaterial and Methods, and in vitro 
phosphorylated proteins were separated by SDS-PAGE and the gel 
exposed for autoradiography. (a)In vitro kinase assay after anti-Syk 
immunoprecipitates ( op). The same immunoprecipitates w re also an- 
alyzed by immunoblotting with anti-Syk antibodies (bottom). (b) In 
vitro kinase assay after anti-Lyn immunoprecipitates (top). Im- 
munoblot with anti-Lyn antibodies (bottom). 
triggered ratio of Syk activity was 2.6 times higher in non 
treated cells than it was in NAC treated cells. Thus NAC 
inhibits antigen-mediated Syk activation, whereas Lyn activa- 
tion is maintained at the same level. 
3.3. Effect of NA C on antigen-mediated calcium mobilization 
We next investigated whether NAC could inhibit he calcium 
mobilization i duced by antigen. RBL-2H3 cells were first sat- 
urated with anti-DNP IgE, loaded with the calcium-sensitive 
dye fura-2, treated or not (for 2 min) with increasing concentra- 
tions of NAC, transferred into the cuvette of a spectrofluoro- 
meter and triggered with 100 ng/ml of DNP-HSA. As expected, 
calcium mobilization was seen after addition of antigen in non 
treated cells. However, NAC inhibited the antigen-mediated 
calcium mobilization i  a dose-dependent manner (Fig. 3). 
3.4. Effect of NA C on antigen-induced and ionomycin-induced 
exocytosis in RBL-2H3 cells 
We then investigated the effects of NAC on the release of 
serotonin induced by antigen or by the calcium ionophore ion- 
omycin. RBL-2H3 cells were loaded with [3H]serotonin, satu- 
rated with anti-DNP IgE and incubated with increasing con- 
centration of NAC (for 2 min) before being triggered (or not) 
with 100 ng/ml of DNP-HSA or with ionomycin (20#M). After 
30 min, the amount of serotonin released in the supernatant was 
quantitated. Treatment of RBL-2H3 cells with NAC did not 
induce serotonin release (Fig. 4, filled bars). However NAC 
treatment inhibited the antigen-induced xocytosis in a dose- 
dependent manner (Fig. 4, grey bars). On the contrary, ionomy- 
cin-induced exocytosis was maintained (Fig. 4, dashed bars) 
except at high NAC concentration (15 mM). Thus NAC inhib- 
its antigen-mediated exocytosis whereas ionomycin-induced ex- 
ocytosis is maintained. 
4.  D iscuss ion  
It is well established that oxidants uch as hydrogen peroxide 
or pervanadate are capable of activating tyrosine kinases possi- 
bly because of the inhibition of phosphatases [23-26]. However, 
the effect of antioxidants on the activity of tyrosine kinases has 
not been studied so far. In this report, we demonstrate hat 
NAC inhibits the activation of Syk and the phosphorylation f 
various substrates induced after engagement of FceRI with 
antigen (Figs. 1 and 2). However, the activation of Lyn is 
maintained (Fig. 2). Therefore it appears that NAC discrimi- 
nates between the two tyrosine kinases Lyn and Syk. The acti- 
vation of Syk is thought o be mediated by the binding of its 
two Src-homology 2 (SH2) domains to the two phosphotyrosi- 
nes of the ARAM (antigen recognition activation motif) motif 
of the FceRI y chain [4~6]. We have recently proposed that the 
phosphorylation of y and of fl is due to Lyn [4]. The data 
presented here support his model of activation. NAC inhibits 
the Syk-related but not the Lyn-related events uch as receptor 
phosphorylation a d seems to uncouple the activation of Syk 
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Fig. 3. NAC inhibits antigen-induced calcium mobilization. RBL-2H3 
cells were saturated with anti-DNP IgE, loaded with fura-2 (2 #M). The 
cells were then incubated, for 2 min with increasing concentrations of 
NAC, as indicated, before being challenged (arrow) with DNP-HSA 
(100 ng/ml). The calcium mobilization was measured on a Photon 
Technology International Deltascan 4000 spectrofluorimeter (cuvette 
system). Triton X-100 (0.1% final) and EGTA (18 mM final) were 
added for calibration (off scale). Calcium concentrations were calcu- 
lated using the published value of 2.24 × 10 -7 for the K d of fura-2 at 
37°C. 
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Fig. 4. Effect of NAC on antigen-mediated an  on ionomycin-mediated 
exocytosis. RBL-2H3 cells were labeled with [3H]serotonin, saturated 
with anti-DNP IgE, and incubated for 2 min with increasing concentra- 
tions of NAC. Cells were then stimulated with 100 ng/ml DNP-HSA 
or 20 ,uM ionomycin or vehicle (as indicated), in the continuous pres- 
ence of NAC. The amount of [3H]serotonin released in the supernatant 
after 30 min is expressed in percent of the total [3H]serotonin corpo- 
rated into the cells. 
from Lyn activation. The mechanism of this differential inhibi- 
tion of the two kinases by NAC remains to be defined. 
Phosphatases but also kinases contain conserved cysteines res- 
idues which are essential for their activity [31,32]. NAC, which 
is a thiol-containing compound, could affect the redox buffer- 
ing capacity of the cytosol thereby affecting the redox status of 
sulfhydryl groups of various enzymes uch as Syk. A difference 
of sensitivity to the redox environment between Lyn and Syk 
could explain the results. 
We also show that NAC inhibits calcium mobilization and 
exocytosis induced by clustering FceRI with antigen. A specific 
inhibition of Syk by NAC could explain our results. Neverthe- 
less, we cannot rule out that NAC has multiple cellular targets, 
some of which could be involved in the degranulation process. 
However, the fact that ionomycin-induced xocytosis is main- 
tained, suggests that the target involved in the inhibition of 
exocytosis by NAC precedes the calcium signal. This would 
also explain why calcium mobilization after FceRI aggregation 
is inhibited. Studies with other kinases and phosphatases will 
be necessary to define the specificity of NAC. Looking at other 
systems hould also be informative. The B cell antigen receptor 
(BCR), like FceRI, activates also the tyrosine kinases Lyn and 
Syk [33]. The T cell antigen receptor (TCR) activates other 
kinases: the Src-family kinase Fyn and Lck and the 72 kDa 
ZAP-70 homologous to Syk [34]. One can speculate that, like 
in mast cells, NAC will inhibit Syk/ZAP-70 kinases in B and 
T cells without affecting the other Src-family kinases. 
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